text: Yo, check it out, let me break it down for you,
  Pimecrolimus, a topical inhibitor, it's true,
  For atopic dermatitis it's second-line, no debate,
  Mild-to-moderate cases, patients two years of age.
  
  But hold up, there's more to this medical tale,
  Pimecrolimus got potential, it's not gonna fail,
  In treating different skin problems, it's been explored,
  Off-label uses, research has fully explored.
  
  Oral lichen planus and seborrheic dermatitis, they say,
  Pimecrolimus got the evidence, it's here to stay,
  It's effective, no doubt, it's been proven right,
  For these conditions, it shines bright in the light.
  
  But listen up, for other cases, it's still in the mix,
  When conventional agents fail, it's a useful fix,
  When first-line treatments don't do the trick,
  Pimecrolimus steps in, it's a slick switch.
  
  Now, let's talk side effects, gotta keep it real,
  Application site reactions, that's the deal,
  Burning sensation, it's the most common thing,
  But it's transient, don't worry, it won't sting.
  
  To summarize, pimecrolimus got the power,
  In multiple skin conditions, it's a game-changer,
  Consider it as an alternative, a new approach,
  When corticosteroids bring adverse effects close.
  
  So there you have it, the rap on pimecrolimus,
  A topical solution with a lot of promise,
  In the world of dermatology, it's making waves,
  A versatile treatment, it's here to stay, yo!